SeaStar Medical raises about $3.3 million as holders exercise warrants at reduced price
SeaStar Medical said holders exercised 854,002 prior warrants for cash at a reduced price of $3.866 per share, for gross proceeds of about $3.3 million before placement agent fees and offering expenses. The offering closed on October 5, 2026, and the company issued new unregistered warrants for up to 1,708,004 shares, which it must register for resale. The filing shows the company will have additional potential share issuance from these new warrants.
Key points
- 854,002 prior warrants exercised at $3.866 per share, versus original exercise prices of $6.38 to $7.62 per share
- Gross proceeds of about $3.3 million before placement agent fees and offering expenses; closing occurred October 5, 2026
- New unregistered warrants for 1,708,004 shares at $3.616 per share, in two series, with the resale registration to be filed within 30 days of October 2, 2026
- H.C. Wainwright & Co. receives a 7.0% cash fee and 1.0% management fee on gross proceeds, plus warrants for 59,780 shares at $4.8325
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.